Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

1.2K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

770
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
770
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

494
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
494
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

1.2K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Challenges in COVID-19 diagnosis.

Bratislavske lekarske listy·2020
Same author

The relationship between neutrophil/lymphocyte, monocyte/ /lymphocyte, platelet/lymphocyte ratios and clinical outcomes after ninety days in patients who were diagnosed as having acute ischemic stroke in the emergency room and underwent a mechanical thro.

Bratislavske lekarske listy·2020
Same author

Role of Gal-3 and H-FABP in the early diagnosis of acute coronary syndrome.

Bratislavske lekarske listy·2019
Same author

Comparison of pentraxin-3 and ischemia-modified albumin with troponin in early diagnosis of acute coronary syndrome.

Bratislavske lekarske listy·2018
Same author

Diagnostic value of copeptin in acute myocardial infarction.

European review for medical and pharmacological sciences·2017
Same author

Predictors of Crimean-Congo hemorrhagic fever in the Emergency Department.

European review for medical and pharmacological sciences·2015

Related Experiment Video

Updated: Apr 3, 2026

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

4.8K

Copeptin: a diagnostic factor for critical patients.

M Yilman1, A K Erenler, A Baydin

  • 1Gazi State Hospital, Samsun, Turkey. abaydin@omu.edu.tr.

European Review for Medical and Pharmacological Sciences
|September 15, 2015
PubMed
Summary

Copeptin, a biomarker derived from arginine vasopressin (AVP), is crucial for predicting patient outcomes and mortality in critical illnesses. This review analyzes its advantages in managing life-threatening conditions.

More Related Videos

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.6K
Endotoxin Activity Assay for the Detection of Whole Blood Endotoxemia in Critically Ill Patients
06:28

Endotoxin Activity Assay for the Detection of Whole Blood Endotoxemia in Critically Ill Patients

Published on: June 24, 2019

10.1K

Related Experiment Videos

Last Updated: Apr 3, 2026

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

4.8K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.6K
Endotoxin Activity Assay for the Detection of Whole Blood Endotoxemia in Critically Ill Patients
06:28

Endotoxin Activity Assay for the Detection of Whole Blood Endotoxemia in Critically Ill Patients

Published on: June 24, 2019

10.1K

Area of Science:

  • Biochemistry
  • Endocrinology
  • Critical Care Medicine

Background:

  • Copeptin is a stable biomarker released equimolarly with arginine vasopressin (AVP), also known as antidiuretic hormone (ADH).
  • The hypothalamic-pituitary-adrenal (HPA) axis activation during stress elevates plasma AVP concentrations.
  • Copeptin is derived from preprovasopressin, alongside neurophysin II and AVP.

Purpose of the Study:

  • To review and analyze the clinical advantages of using copeptin in patients with life-threatening illnesses.
  • To assess copeptin's role as an independent prognostic indicator.

Main Methods:

  • Literature review of medical databases.
  • Analysis of studies investigating copeptin's utility in critical care settings.

Main Results:

  • Copeptin serves as an independent predictor of disease prognosis and mortality.
  • Elevated copeptin levels are associated with increased risk in life-threatening conditions.
  • Its measurement aids in treatment decisions and improving patient survival.

Conclusions:

  • Copeptin is a valuable biomarker for prognosis and mortality assessment in critical illnesses.
  • Its use can enhance patient management strategies and survival rates.
  • Further research can solidify its role in routine clinical practice.